Literature DB >> 27292591

Clinical signs associated with an increased risk of interstitial lung disease: a retrospective study of 101 patients with dermatomyositis.

C C Ang1,2,3, C O Anyanwu1,2, E Robinson1,2, J Okawa1,2, R Feng4, M Fujimoto5, Y Hamaguchi6, V P Werth1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27292591      PMCID： PMC5154776          DOI： 10.1111/bjd.14801

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  11 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

Review 2.  Polymyositis and dermatomyositis (second of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-20       Impact factor: 91.245

3.  Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations.

Authors:  Pamela A Morganroth; Mary Elizabeth Kreider; Joyce Okawa; Lynne Taylor; Victoria P Werth
Journal:  Arch Dermatol       Date:  2010-07

4.  Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.

Authors:  I Marie; P Y Hatron; S Dominique; P Cherin; L Mouthon; J-F Menard
Journal:  Arthritis Rheum       Date:  2011-11

5.  Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study.

Authors:  Yasuhito Hamaguchi; Masataka Kuwana; Kana Hoshino; Minoru Hasegawa; Kenzo Kaji; Takashi Matsushita; Kazuhiro Komura; Motonobu Nakamura; Masanari Kodera; Norihiro Suga; Akira Higashi; Koji Ogusu; Kiyohiro Tsutsui; Akira Furusaki; Hiroshi Tanabe; Shunsuke Sasaoka; Yoshinao Muro; Mika Yoshikawa; Naoko Ishiguro; Masahiro Ayano; Eiji Muroi; Keita Fujikawa; Yukihiro Umeda; Masaaki Kawase; Eriko Mabuchi; Yoshihide Asano; Kinuyo Sodemoto; Mariko Seishima; Hidehiro Yamada; Shinichi Sato; Kazuhiko Takehara; Manabu Fujimoto
Journal:  Arch Dermatol       Date:  2011-04

Review 6.  Pulmonary complications of polymyositis and dermatomyositis.

Authors:  Maryam Fathi; Ingrid E Lundberg; Göran Tornling
Journal:  Semin Respir Crit Care Med       Date:  2007-08       Impact factor: 3.119

7.  Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody.

Authors:  I Marie; L Lahaxe; O Benveniste; K Delavigne; D Adoue; L Mouthon; E Hachulla; J Constans; K Tiev; E Diot; H Levesque; O Boyer; F Jouen
Journal:  Br J Dermatol       Date:  2009-08-29       Impact factor: 9.302

Review 8.  A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.

Authors:  Pedram Gerami; Jennifer M Schope; Lauren McDonald; Hobart W Walling; Richard D Sontheimer
Journal:  J Am Acad Dermatol       Date:  2006-01-23       Impact factor: 11.527

Review 9.  Amyopathic dermatomyositis (dermatomyositis siné myositis). Presentation of six new cases and review of the literature.

Authors:  R L Euwer; R D Sontheimer
Journal:  J Am Acad Dermatol       Date:  1991-06       Impact factor: 11.527

10.  Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.

Authors:  Yasuhito Hamaguchi; Manabu Fujimoto; Takashi Matsushita; Kenzo Kaji; Kazuhiro Komura; Minoru Hasegawa; Masanari Kodera; Eiji Muroi; Keita Fujikawa; Mariko Seishima; Hidehiro Yamada; Ryo Yamada; Shinichi Sato; Kazuhiko Takehara; Masataka Kuwana
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240
View more
  5 in total

Review 1.  Classification of myositis.

Authors:  Ingrid E Lundberg; Marianne de Visser; Victoria P Werth
Journal:  Nat Rev Rheumatol       Date:  2018-04-12       Impact factor: 20.543

Review 2.  "Hiker's feet": a novel cutaneous finding in the inflammatory myopathies.

Authors:  Jacob T Cox; David M Gullotti; Christopher A Mecoli; Arash H Lahouti; Jemima Albayda; Julie Paik; Cheilonda Johnson; Sonye K Danoff; Andrew L Mammen; Lisa Christopher-Stine
Journal:  Clin Rheumatol       Date:  2017-04-07       Impact factor: 2.980

Review 3.  Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.

Authors:  Paige W Wolstencroft; David F Fiorentino
Journal:  Curr Rheumatol Rep       Date:  2018-04-10       Impact factor: 4.592

4.  Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies.

Authors:  Minna Jiang; Xin Dong; Yi Zheng
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

Review 5.  Recent developments in classification criteria and diagnosis guidelines for idiopathic inflammatory myopathies.

Authors:  Alexander Oldroyd; Hector Chinoy
Journal:  Curr Opin Rheumatol       Date:  2018-11       Impact factor: 5.006
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.